AtheroGenics To Present At Thomas Weisel Partners' Healthcare Conference On September 6, 2006

ATLANTA, GA -- (MARKET WIRE) -- August 29, 2006 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present a company overview and update at the Thomas Weisel Partners Healthcare Conference on Wednesday, September 6, 2006, at 1:30 p.m. EDT at The Four Seasons Hotel in Boston, Massachusetts.